Dechert advised Mason Financial Holdings Limited, a Hong Kong listed company, on its approximately HK$214.2 million acquisition of the entire issued share capital of two target companies, which collectively hold approximately 48.3% of DiagCor Technology Limited, the holding company of a group of leading molecular diagnostics companies in Hong Kong. The transaction closed on January 4, 2017. This transaction allows our client to further capture growth opportunities in the life sciences and premium medical service industry in Hong Kong and creates synergies with its HK$513.9 million acquisition of a group of leading private assisted reproductive service providers in Hong Kong.

The transaction was led by corporate partner, Stephen Chan and assisted by associate Nicole Wong of Dechert’s Hong Kong office.